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0929-6441/ª 2014, Elsevier Taiwan LLBackground: The goal of this study is to validate the clinical utility and define the procedure
setting of minimally invasive core biopsy that is performed under ultrasound guidance with
small-gauge needles (USCB) in head and neck tumors.
Materials and methods: A consecutive 56 patients with head and neck tumors received USCB
with informed consents. Patients received USCB with different gauges of core needles
randomly. The adequacy rate of the specimen and other clinical parameters were analyzed.
The adequacy is defined as the target lesion is taken under ultrasound and specific diagnosis
could be made by the specimen.
Results: The overall diagnostic adequacy rate of USCB was 91%. Among different needle gauges
of USCB, the 18-gauge group demonstrated a 100% adequate rate, a lower anesthetic demand
(16.6%), and shorter postprocedure bleeding time (3.0  1.4 minutes), showing significant dif-
ferences when compared with others. No immediate or late complications were noted after
procedure in all patients.
Conclusion: USCB is minimally invasive and provides pathological information for diagnosis. It
is a precise, safe, and office-based procedure and is suggested to be included in the diagnosis
of head and neck tumors.
ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
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Head and neck tumors are frequently encountered in clinical
practice, and always pose demanding challenges for accu-
rate diagnosis and appropriate treatments. To make definite
diagnoses of head and neck masses, many disease entities
shouldbedifferentiated, ranging fromcongenital anomalies,
infection, and inflammation to neoplastic lesions [1].
Because of the lengthy list of differential diagnosis of head
and neck tumors, harvesting a tissue specimen for making a
pathological diagnosis is a mandatory requirement in treat-
ing head and neck tumors.
In tumor tissue harvest, open biopsy remains the standard
procedure for decades. Because of its nature of surgical
intervention, the procedure of open biopsy has several dis-
advantages including wound and scar formation, time con-
sumption, higher cost, and contraindications for patients
with multiple comorbidities. In addition, open biopsy is not
generally recommended because of its invasiveness and the
possibility of complicating subsequent management. [2e4].
However, fine needle aspiration (FNA) has been used for
small wounds and is free of anesthesia, is better tolerated,
and has few complications [5]. To make the definite diag-
nosis by FNA, the accuracy is largely dependent on cytopa-
thological expertise and techniques [6]. Nonetheless, even
with experienced surgeons, the incidence of nondiagnostic
results is approximately 10e15%. Most importantly, it is
difficult to grade and classify tumors by FNA because the
results are based on cytological analysis.
In light of the drawbacks related to open biopsy and FNA,
core biopsy (CB) is another choice of diagnostic procedure. It
is a well-established, tissue-obtaining technique that has
been widely applied in many medical specialties, such as
breast and renal tumors [7e13]. In the head and neck, it has
been successfully used in tissue harvest of lymph nodes,
thyroid lesions, parotid tumors, and pediatric craniofacial
masses [10,13e18]. For head and neck malignancy, CB is
suggested to be a safe and efficient tool for tissue harvest
[19,20], especially when guided by ultrasound [14].
However, needles with 12e16 gauges, which were orig-
inally designed for breast and abdomen lesions, were used
for head and neck tumors in the previous attempts
[19,21e23]. It is believed that needles with larger gauges
are associated with an increased possibility of bleeding,
wound dehiscence, anesthetic requirement, and tumor
seeding potential [24,25]. These disadvantages made large-
gauge CB clinically impractical for head and neck tumors.
Core needles with smaller gauges had been tried in cervi-
cofacial lesions [8,26e29]. Until now, a comprehensive
study that defines the CB procedure for a better diagnostic
yield and utility in head and neck tumors is still lacking.
In this study, we will verify clinical utility of ultrasound-
guided small-gauge core biopsy (USCB) and establish the
procedure of USCB specific to head and neck tumors.
Materials and methods
Fifty-six consecutive patients receiving USCB for their head
and neck mass were enrolled in this study. Complete
ear, nose, and throat field evaluation was performed in
each patient and head and neck mass was confirmed byultrasound examination. The study protocol was approved
by the Institutional Review Board of National Taiwan Uni-
versity Hospital. Tumors smaller than 1 cm or with only
cystic contents that were inappropriate for this procedure
were excluded [30]. All eligible patients received sampling
procedures with informed consent.
For the USCB procedure, patients were in the supine po-
sition with the neck hyperextended. A panoramic ultrasound
examination of head and neck was performed prudently in
each patient with a 12 MHz linear probe (Hitachi Hivision
Avius with EUP-L75, Hitachi Aloka Medical, Tokyo, Japan or
Toshiba Aplio SSA790 diagnostic ultrasound system, Tochigi-
ken, Japan). Sonographic featuresand locations of the lesions
were recorded. A color duplex model was used to avoid
vasculature and exclude the presence of hypervascular
tumor. After identifying the lesion of interest, the overlying
skin was disinfected and draped. Under echo-guidance, the
automatic adjustable biopsy needles (Temno Evolution Bi-
opsy Devices, Cardinal Health Inc., Dublin, USA) that were 16
gauge (G), 18 G, or 20 G were used randomly for specimen
harvest (Fig. 1). We used the core needles randomly in the
beginningbyapatients’ chart number.However, pathological
information tended to be satisfied in smaller needles during
the study, so we used only 18 G and 20 G later. Two needle
throw lengths (10mmor 20mm)could be adjusted for precise
sampling. Local anesthesia (2% xylocaine)was injected at the
subcutaneous area for core needle insertion. Local anes-
thesia was used only by patients’ requests after detailed
discussion. The core needle was inserted under ultrasound
guidance like FNA, without any skin incision. We identified
the needle into the mass under ultrasound and then pushed
the innerneedle forward.Then, thecoreneedlewasfiredand
the specimen was retained in the needle notch. Only one
needle pass was done to avoid any possibility of tumor seed-
ing.Bleedingwascontrolledwithpressure and thewoundwas
examined every minute to record bleeding time. Possible
complications in the literature, including bleeding, hema-
toma, nerve palsy, and pneumothorax, were also monitored
[25]. After the procedure, the patient was observed for 20
minutes before leaving, and followed up in regular clinic
visits. All harvested samples were sent for staining and
microscopic examination. The related clinical parameters
and pathological findings were recorded and analyzed.
The diagnostic adequacy is defined as a definite diag-
nosis could be concluded by the specimen retrieved from
USCB procedure. The adequacy rate was obtained by
dividing the number of adequate samplings with the total
number of specimens. The comparison of adequate rate
was analyzed by the Fisher’s exact test. The comparison of
local anesthesia requirement was analyzed by a logistic
regression test to calculate the odds ratio between
different groups. The comparison of bleeding time between
different USCB gauges was analyzed by the Kruskal-wallis
post-hoc test. All statistical analysis was performed by IBM
SPSS Statistics Version 22.0 (IBM Corporation, USA), and
p < 0.05 was regarded as significant in all tests.Results
In all 56 patients receiving USCB, there were 36 male and
20 female patients. The average age was 51 years
Fig. 1 Ultrasound-guided small-gauge core biopsy (USCB) procedure. (A) The needle was inserted into the tumor under ultra-
sound guidance. After localizing the mass and needle, the biopsy was taken. (B) The specimen harvested in the needle notch. (C)
Surface wound after USCB procedure (arrow).
Table 2 Diagnosis by ultrasound-guided, small-gauge core
biopsy.




Lymphoma, B cell, low grade 1
Lymphoma, B cell, high grade 1
Hodgkin’s lymphoma 1
Olfactory neuroblastoma 1
Carcinoma, TTF-1 (þ), metastasis 1
Carcinoma, metastasis 2






Branchial cleft cyst 1
154 T.-L. Yang, C.-N. Chen(16e96 years). The locations of head and neck tumors and
their pathological diagnosis are listed in Tables 1 and 2.
The adequate rate was 91.1% for USCB totally. In the
current study, 11 patients received a 16-G needle, 18
received 18-G needles, and 27 received 20-G needles. The
adequate rate of diagnosis for 16-G, 18-G, and 20-G USCB
was 100.0%, 100.0%, and 81.4%, respectively. In the com-
parison of each group, it was likely that the adequate rate
of USCB was higher in the group with larger needle gauges.
However, the difference was not significant statistically
(Table 3).
The pain was more tolerable in smaller core needle size.
Most patients didn’t need local anesthesia by using 18- and
20-G needles (Odds ratio: 0.02 in 18 G and 0.016 in 20 G),
with significant difference from 16 G (Table 4).
When bleeding time was measured and compared, it
declined as the needle gauges decreased. Bleeding time
was 4.1  0.8 minutes in 16-G group, 3.0  1.4 minutes in
the 18-G group, and 2.6  0.7 minutes in the 20-G group.
There existed a significant difference between 16 G and
other groups, which indicated that bleeding was correlated
with needle gauge of core biopsy (Table 5).
In our series, no immediate complications such as un-
controllable bleeding, infection, or nerve injury were
noted during and after the entire procedure for all pa-




Age (y) 50.9 þ 22.9
Size (cm) 2.26 þ 1.02
Location









USCB Z ultrasound-guided small-gauge core biopsy.(Fig. 1). Two representative cases receiving USCB for
diagnosis were demonstrated in Figs. 2 and 3. In the 1-year
follow-up, no late complications or tumor seeding were
found in USCB.Benign fibroadipose tissue 12










MALToma Z mucosa-associated lymphoid tissue lymphoma.
Table 3 Adequate rate among core needles with different
gauge sizes.
USCB Case no. Adequate rate (%) p
16 G 11 100 0.052
18 G 18 100
20 G 27 81.4
Total 56 91
USCB Z ultrasound-guided small-gauge core biopsy.





16 G 6/11 (54.5%) 1 0.058
18 G 3/18 (16.6%) 0.02 0.041
20 G 5/27 (18.5%) 0.016 0.033




16 G 4.1  0.8 0.001
18 G 3.0  1.4
20 G 2.6  0.7
Group comparison p
16 G vs 18 G 0.008
18 G vs 20 G > 0.99
16 G vs 20 G 0.001
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In the current study, clinical utility of USCB in diagnosing
head and neck tumor is demonstrated. The USCB is a pre-
cisely diagnostic, cost-effective, and patient-friendly pro-
cedure, which can be used in a variety of head and neck
tumors by providing adequate and useful information for
pathological diagnosis.
USCB is a safe procedure in sampling head and neck
tumors. In other studies of CB by using needles with larger
sizes, immediate and late complications including bleedingFig. 2 An 86-year-old man had right neck swelling for 3 months. (
Level I to Level V. (B) Neck ultrasound revealed a confluent, heterog
Under echo-guidance, core needle biopsy was performed smoothly.
B is the throw of the core needle. (D) Pathology results revealed a h
which is positive for (E) CD20 (400), and (F) CD3 (400).and hematoma, temporary nerve palsy, delayed wound
healing, major vessel injury, and pneumothorax had been
reported [25]. Nonetheless, in our series, there is no im-
mediate complication after procedure. The wound is as
small as that of FNA, and bleeding time is under control. By
echo-guidance, the route of the biopsy needle is closely
monitored. Vascular structures surrounding the tumor can
be easily avoided to decrease complication risk. In addi-
tion, an automatic adjustable core needle was used in our
patients instead of the automatic needle gun reported in
previous studies [19,21,27,28]. The inner trocar of the
adjustable needle, which is designed to define the most
distant biopsy site, is important in making the procedure
safer by restricting the outer cutting trocar. It can be
immediately adjusted by tumor size. Additionally, this
procedure can be performed in older patients, as shown in
our results. Therefore, the device and procedure applied in
USCB is beneficial to diminish sampling-related
complications.
In addition to being a safe procedure, USCB is a precise
sampling technique. Under ultrasound guidance, the area
of target tumors can be clearly delineated. For instance,
cystic and necrotic area within the tumor can be easily
avoided. The adequacy rate of USCB is 91.1% in our series,
which is in accordance with other studies using CB for head
and neck sampling [14,19,27,28]. Furthermore, the ade-
quacy rate of USCB is based on pathological diagnosis rather
than cytological results, which is more accurate and useful
in clinical applications. By using USCB, it is possible to make
a definite pathological diagnosis by evaluating histological
structure as well as applying special stains to assist differ-
ential diagnosis.
USCB is regarded as a patient-friendly procedure. USCB
can be performed immediately during sonographic exami-
nation. Because sonographic examination is readily avail-
able at outpatient clinics, USCB can be an office-based
procedure. It infers a convenient test with a low cost.A) Magnetic resonance imaging revealed a mass extending from
eneous, ill-defined, and hypoechoic lesion at the right neck. (C)
Arrow A defined the needle tip; the space between arrow A and
igh grade B cell lymphoma (hematoxylin and eosin stain, 20),
Fig. 3 A 73-year-old man had bilateral parotid tumors for 1 year. (A) Computed tomography scan shows bilateral parotid gland
swelling. (B) Sonography revealed a well-defined ovoid hypoechoic mass. (C) Pathological diagnosis of ultrasound-guided small-
gauge core biopsy-harvested specimen is Warthin tumor (hematoxylin and eosin stain, 100).
156 T.-L. Yang, C.-N. ChenMoreover, because the definite pathological diagnosis could
be achieved via small needle wound, surgical intervention
is unnecessary for many patients. It is particularly benefi-
cial for patients who are vulnerable to operation, such as
the infirm or those who have undergone radiation treat-
ment [27]. Together, these features make USCB friendly to
patients with head and neck tumors.
Tumor seeding and procedure-related complications are
main issues that require additional study. It has been re-
ported that significant tumor cell dissemination is seldom
found in FNA biopsy by using a 21-G needle [31,32].
Although tumor seeding caused by CB also is rarely re-
ported, some studies still conclude that tumor seeding is
related to needle diameter, tumor feature, and anatomical
site of puncture [24,33]. Therefore, to diminish the risk of
tumor seeding and related complications, a smaller gauge
core needle is more appropriate in the delicate anatomical
region such as the head and neck. We use a smaller gauge
and only one needle pass for each patient to avoid tumor
seeding before malignancy is excluded. In this study, no
tumor seeding was found in more than 1-year follow-up. It
is acknowledged that a longer follow-up period is required
to confirm the possibility of tumor seeding in USCB, current
results offer preliminary evidence that the risk is clinically
acceptable.
In the current study, a definitive diagnosis could not be
made in five patients. All samples were harvested by 20-G
needles with 10 mm throws. It may result from a small
specimen without intact structure for evaluation. With a
20-G needle, the thickness of the specimen is smaller than
0.9 mm. With a 10-mm needle throw, the cannula thrustmay cut inadequate tissue for diagnosis, especially in a
hypervascular or lymphoma-like lesion. To overcome this
shortage, a longer needle with 20-mm throw was used to
obtain specimens instead. By using the revised procedure in
clinical practice, no inadequate results had been found
thereafter. In addition, we find that 18-G USCB can achieve
a 100% adequacy rate and the same patient tolerance as a
20-G needle (low anesthesia rate and less bleeding time).
In conclusion, USCB is a precise and informative diag-
nostic procedure for head and neck tumors. It is a low-cost
and office-based technique that can be easily performed.
For most head and neck tumors, the most suitable gauge
size is 18 G. It is competent in obtaining a high adequacy
rate, providing pathological information, and causing less
discomfort and fewer complications. Based on the advan-
tages of minimal invasiveness and cost-effectiveness, USCB
with an 18-G needle is suggested to be included in the
battery of diagnostic procedures of head and neck tumors.
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